In clinically relevant rodent models of hyperammonemia (genetic ornithine transcarbamylase deficiency and bile duct ligation–induced cirrhosis), TLR4 inhibition reduced circulating ammonia. The gene discussed is TLR4; the disease is Hyperammonemia.